More News

25 Jul 2019 REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative Diseases
24 Jul 2019 Ligand Acquires Ab Initio Biotherapeutics, an Antigen-Discovery Company
23 Jul 2019 IVERIC bio Announces Successful Advancement of LCA10 Minigene Program and Expansion of Orphan Gene Therapy Portfolio with USH2A-Related Inherited Retinal Diseases Program
23 Jul 2019 Shionogi announces out-licensing agreement with AMR Centre on COT-143, a humanized monoclonal antibody targeting the PcrV protein of Pseudomonas aeruginosa
23 Jul 2019 DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product
21 Jul 2019 Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
18 Jul 2019 Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
18 Jul 2019 Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
18 Jul 2019 Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
17 Jul 2019 PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
17 Jul 2019 Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
17 Jul 2019 Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery
16 Jul 2019 Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
16 Jul 2019 Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement With Genentech to Discover Novel Remyelinating Therapies
16 Jul 2019 Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech
16 Jul 2019 Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California
15 Jul 2019 AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
15 Jul 2019 Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
15 Jul 2019 Recordati to acquire worldwide rights to Signifor® and Osilodrostat (LCI699)
15 Jul 2019 Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
12 Jul 2019 Genmab and BliNK Biomedical Enter into Commercial License Agreement
11 Jul 2019 Report Package: Bispecific Antibodies
11 Jul 2019 vasopharm Closes € 9.5 million Financing Round
10 Jul 2019 AiCuris and Lysando join forces in the fight against antimicrobial resistance
10 Jul 2019 Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top